Skip to main content
. 2023 Oct 31;9(5):232–240. doi: 10.52601/bpr.2023.230013

Table 6. hMyoblast cell differentiation medium (MDM).

Composition Volume Final concentration
High glucose DMEM 475 mL
Horse serum 10 mL 2% (v/v)
GlutaMAXTM-1 5 mL 2 mmol/L
MEM NEAA 5 mL 0.1 mmol/L
Penicillin Streptomycin 5 mL 1% (v/v)
PlasmocinTM Treatment 50 μL 0.01% (v/v)